HOME >> BIOLOGY >> NEWS
Intercure Scientific Advisory Board convenes to review companys resperate medical device for hypertension

Princeton, NJ, July 23 InterCure, Ltd. (http://www.intercure.com), an innovative medical technology company, convened its Scientific Advisory Board (SAB) to focus on the companys RESPeRATE (http://www.resperate.com) medical device, during the recent annual meeting of the American Society of Hypertension.

"We were grateful for this opportunity to meet with our world-class Scientific Advisory Board," explained Paul Sheils, Chief Executive Officer of InterCure. "These are some of the worlds most distinguished experts on hypertension and the people involved in setting the guidelines and standards for the medical community to manage hypertension. It means a great deal that they support RESPeRATE as an effective treatment of hypertension."

The Scientific Advisory Board (SAB) is composed of several of the worlds most renowned opinion-leaders in the field of hypertension, including:

Henry R. Black, M.D., Head of the Preventive Medicine Department at Rush University, Chicago, IL, who served on the Executive Committee of the Sixth Joint National Committee on the Detection, Evaluation, and Treatment of Hypertension (JNC VI), served on the Executive Committee of the American Heart Association Council on High Blood Pressure Research, and was a member of the Executive Committee of the American Society of Hypertension;

Jay N. Cohn, M.D., Professor of Medicine, Cardiovascular Division, Department of Medicine at the University of Minnesota Medical School in Minneapolis, President of the Heart Failure Society of America, President of the International Society of Hypertension, past President of The American Society of Hypertension, former officer of the American Heart Association, and former chairman of the Cardiorenal Advisory Committee of the Food and Drug Administration;

Ehud Grossman, M.D., Head of the Department of Internal Medicine at the Chaim Sheba Medical
'"/>

Contact: InterCure
support@intercure.com
Marcus Communications
23-Jul-2001


Page: 1 2 3 4

Related biology news :

1. 2nd media alert First Scientific Conference on Childhood Leukaemia
2. First International Scientific Conference on Childhood Leukaemia
3. Scientific publications: Time for change
4. Dr. Walter Reich, Ph.D., receives prestigious AAAS 2003 Scientific Freedom and Responsibility Award
5. Press briefings at The Gerontological Society of Americas 56th Annual Scientific Meeting
6. Scientific study of twins shows forgiveness has genetic component
7. Scientific equipment including the first European student experiment reaches the ISS
8. Emorys CancerQuest wins top Web award from Scientific American
9. Scientific innovations, social issues and biobusiness at Bio Tech Helsinki 03
10. Scientific balancing act dominates AAAS top ten list of science policy stories for 2002
11. Acorda Therapeutics receives L.W. Freeman Award for Scientific Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading provider ... new solution aimed at combatting fraud, waste and abuse ... introduced at the Action on Disaster Relief conference in ... point for UN agencies and foreign assistance organizations throughout ... waste and abuse are a largely unacknowledged problem in ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds simple ... sock that monitors vital signs and alerts parents ... infant,s oxygen saturation level drops. But pediatric experts ... to parents, with no evidence of medical benefits, ... are marketed aggressively to parents of healthy babies, ...
(Date:1/19/2017)... , Jan. 19, 2017 Sensory ... experience and security for consumer electronics, and ... processing systems and cybersecurity solutions, today announced a ... and financial institutions worldwide to bolster security of ... end-to-end secure user authentication platforms they offer, innerCore ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... ... February 17, 2017 , ... ... business in Hong Kong. , Nerium International is proud to introduce its Age-Defying ... Contour Cream, NeriumAD™ Formula to consumers across Hong Kong. The luxury skincare products ...
(Date:2/17/2017)... Mass. , Feb. 17, 2017  If ... small tumor had a mutation-conferring resistance to chemotherapy, ... Recently, genomics research has focused on finding these ... or even from circulating tumor DNA in blood ... new oncology therapeutics. Unfortunately, however, detecting ...
(Date:2/16/2017)... ... February 16, 2017 , ... Avomeen & MichBio will be hosting a BioMixer ... at Avomeen Analytical Services (4840 Venture Dr., Ann Arbor, Michigan 48108). BioMixers are ... opportunity to interact with peers, make new connections and talk bio biz. , Cost:, ...
(Date:2/16/2017)... , Feb. 16, 2017  ArmaGen, Inc., a ... therapies to treat severe neurological disorders, today reported ... with AGT-181, the company,s investigational therapy for the ... as mucopolysaccharidosis type I, or MPS I). The ... (POC) study, presented today at the 13 th ...
Breaking Biology Technology:
Cached News: